These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 26202500)
1. MSC-based therapies in solid organ transplantation. Benseler V; Obermajer N; Johnson CL; Soeder Y; Dahlke MD; Popp FC Hepatol Int; 2014 Apr; 8(2):179-84. PubMed ID: 26202500 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal cells to promote solid organ transplantation tolerance. Casiraghi F; Perico N; Remuzzi G Curr Opin Organ Transplant; 2013 Feb; 18(1):51-8. PubMed ID: 23254705 [TBL] [Abstract][Full Text] [Related]
3. Isogeneic MSC application in a rat model of acute renal allograft rejection modulates immune response but does not prolong allograft survival. Koch M; Lehnhardt A; Hu X; Brunswig-Spickenheier B; Stolk M; Bröcker V; Noriega M; Seifert M; Lange C Transpl Immunol; 2013 Dec; 29(1-4):43-50. PubMed ID: 23994720 [TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate. Popp FC; Eggenhofer E; Renner P; Slowik P; Lang SA; Kaspar H; Geissler EK; Piso P; Schlitt HJ; Dahlke MH Transpl Immunol; 2008 Nov; 20(1-2):55-60. PubMed ID: 18762258 [TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells: application for solid-organ transplantation. Roemeling-van Rhijn M; Weimar W; Hoogduijn MJ Curr Opin Organ Transplant; 2012 Feb; 17(1):55-62. PubMed ID: 22186092 [TBL] [Abstract][Full Text] [Related]
6. Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model. Eggenhofer E; Renner P; Soeder Y; Popp FC; Hoogduijn MJ; Geissler EK; Schlitt HJ; Dahlke MH Transpl Immunol; 2011 Sep; 25(2-3):141-7. PubMed ID: 21704160 [TBL] [Abstract][Full Text] [Related]
7. Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study. Peng Y; Ke M; Xu L; Liu L; Chen X; Xia W; Li X; Chen Z; Ma J; Liao D; Li G; Fang J; Pan G; Xiang AP Transplantation; 2013 Jan; 95(1):161-8. PubMed ID: 23263506 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cells in renal transplantation: opportunities and challenges. Casiraghi F; Perico N; Cortinovis M; Remuzzi G Nat Rev Nephrol; 2016 Apr; 12(4):241-53. PubMed ID: 26853275 [TBL] [Abstract][Full Text] [Related]
9. Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation. Crop M; Baan C; Weimar W; Hoogduijn M Transpl Int; 2009 Apr; 22(4):365-76. PubMed ID: 19000235 [TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients. Reinders ME; Bank JR; Dreyer GJ; Roelofs H; Heidt S; Roelen DL; Al Huurman V; Lindeman J; van Kooten C; Claas FH; Fibbe WE; Rabelink TJ; de Fijter JW J Transl Med; 2014 Dec; 12():331. PubMed ID: 25491391 [TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation. Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257 [TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Inoue S; Popp FC; Koehl GE; Piso P; Schlitt HJ; Geissler EK; Dahlke MH Transplantation; 2006 Jun; 81(11):1589-95. PubMed ID: 16770249 [TBL] [Abstract][Full Text] [Related]
19. Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy. Naji A; Rouas-Freiss N; Durrbach A; Carosella ED; Sensébé L; Deschaseaux F Stem Cells; 2013 Nov; 31(11):2296-303. PubMed ID: 23922260 [TBL] [Abstract][Full Text] [Related]